Bradley Foster & Sargent Inc. CT Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bradley Foster & Sargent Inc. CT raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 41,908 shares of the medical equipment provider's stock after acquiring an additional 719 shares during the quarter. Bradley Foster & Sargent Inc. CT's holdings in Intuitive Surgical were worth $21,874,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Sierra Ocean LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $40,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on ISRG shares. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Finally, Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.1 %

Shares of ISRG stock traded up $0.51 on Monday, reaching $592.30. 726,575 shares of the stock were exchanged, compared to its average volume of 1,695,098. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market capitalization of $210.97 billion, a price-to-earnings ratio of 92.62, a PEG ratio of 5.85 and a beta of 1.39. The business's 50 day moving average price is $565.45 and its 200 day moving average price is $525.60.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.